Moreover, in a mouse model of DMD, which shows elevated circulating skeletal muscle-derived FGF21 (Zhou et al., 2018), blockage of FGF21’s action using a neutralization antibody, resulted in significantly increased bone mass and improved quality of bone tissues (Li et al., 2020). Here, FGF21 is linked to Duchenne muscular dystrophy.